"Atrial Fibrillation Market," The atrial fibrillation market size was valued at $1,825.85 million in 2020, and is estimated to reach $3.4 Billion by 2030, growing at a CAGR of 6.4% from 2021 to 2030.
Atrial fibrillation is a type of irregular heartbeat characterized by rapid and irregular beating. Blood may clot and congest in the atria at the same time because of insufficient blood received by ventricles. These clots can enter the circulation and reach the brain, causing stroke. The transmission of electrical impulses to the lower heart chambers is disrupted in atrial fibrillation, which causes a rapid, slow, or irregular heartbeat. During atrial fibrillation, upper chamber and lower chamber of the heart beat irregularly, chaotically, and out of sync, which causes shortness of breath, chest pain, weakness, ad lightheadedness or fainting.
Key Findings Of The Study
The report provides an extensive analysis of the current and emerging atrial fibrillation market trends and dynamics.
Depending on type, the surgical segment dominated the atrial fibrillation market, in terms of revenue in 2020 and is projected to grow at a significant CAGR during the forecast period.
By technology, the radiofrequency segment registered highest revenue in 2020.
By end user the hospitals segment registered highest revenue in 2020.
Asia-Pacific is projected to register highest growth rate in the coming years.
The report provides atrial fibrillation market forecast analysis from 2021 to 2030.
Depending on type, the surgical segment dominated the atrial fibrillation market, in terms of revenue in 2020 and is projected to grow at a significant CAGR during the forecast period.
The key players within the atrial fibrillation market are profiled in this report, and their strategies are analyzed thoroughly, which help understand competitive outlook of the atrial fibrillation industry.
Atrial fibrillation is a type of irregular heartbeat characterized by rapid and irregular beating. Blood may clot and congest in the atria at the same time because of insufficient blood received by ventricles. These clots can enter the circulation and reach the brain, causing stroke. The transmission of electrical impulses to the lower heart chambers is disrupted in atrial fibrillation, which causes a rapid, slow, or irregular heartbeat. During atrial fibrillation, upper chamber and lower chamber of the heart beat irregularly, chaotically, and out of sync, which causes shortness of breath, chest pain, weakness, ad lightheadedness or fainting.
Key Market Segments
BY TYPE
Surgical
Non-Surgical
BY TECHNOLOGY
Radiofrequency
Laser
Cryotherapy
Others
BY END USER
Hospitals
Specialty Clinics
Others
However, during the COVID-19 pandemic lockdown, various manufacturers in the atrial fibrillation market had to stop their business in countries, such as China, the U.S., and India, which negatively affected the atrial fibrillation market growth. This break directly impacted the sales and decline in atrial fibrillation market share. In addition, lack of manpower and raw materials also constricted supply of equipment of atrial fibrillation, which negatively influenced the growth of the market. However, reopening of production facilities and introduction of vaccines for COVID-19 are anticipated to lead to re-opening of atrial fibrillation companies.
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/479
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
